Covered recipient · General Payments record
JOHN R PINKSTON
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$531.81
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $492.26 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $131.61 | 7 |
| Novo Nordisk AS | $90.55 | 5 |
| ABBVIE INC. | $64.83 | 3 |
| Astellas Pharma US Inc | $32.18 | 2 |
| Acerta Pharma LLC | $30.06 | 2 |
| Phathom Pharmaceuticals, Inc. | $29.62 | 1 |
| Medtronic, Inc. | $24.11 | 1 |
| CVRx Inc. | $21.25 | 1 |
| Exact Sciences Corporation | $18.75 | 1 |
| E.R. Squibb & Sons, L.L.C. | $18.05 | 1 |
| DEXCOM, INC. | $18.00 | 1 |
| Amgen Inc. | $13.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.31 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105272138 | CMS |
| ABBVIE INC. | $18.58 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105272142 | CMS |
| ABBVIE INC. | $26.94 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105272146 | CMS |
| Amgen Inc. | $13.25 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117354531 | CMS |
| Astellas Pharma US Inc | $14.32 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139350745 | CMS |
| Astellas Pharma US Inc | $17.86 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139409293 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.36 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105746175 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.70 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105798044 | CMS |
| CVRx, Inc. | $21.25 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133856918 | CMS |
| Dexcom, Inc. | $18.00 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153310013 | CMS |
| E.R. Squibb & Sons, L.L.C. | $18.05 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101382678 | CMS |
| Exact Sciences Corporation | $18.75 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114836412 | CMS |
| Lilly USA, LLC | $21.39 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135060020 | CMS |
| Lilly USA, LLC | $21.65 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135085180 | CMS |
| Lilly USA, LLC | $21.46 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135072325 | CMS |
| Lilly USA, LLC | $13.38 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135060516 | CMS |
| Lilly USA, LLC | $14.17 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135070309 | CMS |
| Lilly USA, LLC | $15.17 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135070489 | CMS |
| Lilly USA, LLC | $24.39 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135060022 | CMS |
| Medtronic, Inc. | $24.11 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117104317 | CMS |
| Novo Nordisk Inc | $15.28 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097290779 | CMS |
| Novo Nordisk Inc | $18.39 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097041420 | CMS |
| Novo Nordisk Inc | $15.28 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096674298 | CMS |
| Novo Nordisk Inc | $20.35 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097330652 | CMS |
| Novo Nordisk Inc | $21.25 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096736493 | CMS |
| Phathom Pharmaceuticals, Inc. | $29.62 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151110582 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.